Articles from Hims & Hers

For most Americans, weight is more than just a number. It shapes our health, our mood, our confidence, our spending, and the decisions we make in our day to day lives. In fact, 75% of us think about our weight every single day, and 14% say it’s constantly on our minds.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is proud to announce its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impact on their industries and on society at large.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that Hims & Hers customers will now be able to supplement their treatment plan with daily meal replacement bars and shakes to support them on their comprehensive weight loss journey.

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSEHIMS), the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety. Hims & Hers continues to prioritize safety across its platform, offerings, and leadership so that every customer can have the confidence that the solutions they have access to are safe, high-quality, and personalized for their needs.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today shared more data on the challenges Americans are facing when trying to access branded GLP-1 medication and introduced a GLP-1 Supply Tracker, where individuals can be a part of advocating for better access to the medications they need.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2024 in a shareholder letter that is posted at investors.hims.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today released a white paper entitled “Hims & Hers Weight Loss: A Look at Early Customer Experiences and Outcomes” which outlines how customers are achieving positive outcomes with compounded medications through our weight loss program. Early customer results indicate they are managing side effects well, staying on treatment, and overall feeling healthier.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dr. Jessica Shepherd is joining as the first Chief Medical Officer of Hers. As the company invests further in personalized healthcare designed for women, Dr. Shepherd will guide the clinical expertise that forms the foundation of the Hers brand across sexual health, dermatology, weight loss, and mental health.

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter financial results after the market closes on Monday, November 4, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform committed to breaking down barriers to safe and affordable healthcare, today announced access to the most common compounded GLP-1 subscriptions for as low as $99 a month for eligible U.S. military, veterans, teachers, nurses and first responders.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the second quarter ended June 30, 2024 in a shareholder letter that is posted at investors.hims.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Kåre Schultz to the company’s Board of Directors.

Hims & Hers Health, Inc. ("Hims & Hers") (NYSEHIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc., the leading health and wellness platform, today announced the addition of GLP-1 injections to its comprehensive weight loss portfolio, giving customers an affordable way to consistently access safe, high-quality weight loss treatment.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Anja Manuel to the company’s Board of Directors. Ms. Manuel is a co-founder and principal in Rice, Hadley, Gates & Manuel LLC, a strategic consulting firm founded in 2009 that helps U.S. companies navigate international markets and regulatory issues, and a former U.S. government official.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, is today announcing its partnership with drag superstars Violet Chachki & Gottmik to launch the first-ever “No Gorge” Pride Tour 2022 from May 20 to July 14. Hims & Hers has united with the tour as its exclusive partner, which includes a unique collaboration with The Trevor Project as well as a campaign with the drag queens to destigmatize mental health and hair loss.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced a partnership with health and wellness brand GNC Holdings, LLC (GNC) to offer consumers health and wellness solutions at select GNC stores nationwide as well as online at GNC.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform that provides modern and personalized health and wellness experiences, in partnership with OnePoll has conducted a new survey to determine how Americans are feeling about returning to the normalities of pre-pandemic life as well as current perceptions of mental health support to gain a better understanding of the current climate and mental health needs during this transitional time.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform that provides modern and personalized health and wellness experiences, in partnership with OnePoll has conducted a new survey to determine how Americans are feeling about returning to the normalities of pre-pandemic life as well as current perceptions of mental health support to gain a better understanding of the current climate and mental health needs during this transitional time.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced a partnership with Urban Outfitters, Inc. (NASDAQURBN), a leading lifestyle products and services company that is dedicated to inspiring their customers through a unique combination of product, creativity and cultural understanding — which will offer personalized health and wellness solutions, starting with the availability of select Hims products, on urbanoutfitters.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform that provides modern and personalized health and wellness experiences, has launched two new product bundles that speak to the growing consumer demand for safe, quality sexual health offerings without sacrificing the playful, empowering positioning the brand’s customers know and love. With nearly half of consumers engaging in more sexual experimentation following the onset of the pandemic and the global sex toy market projected to reach $36.1 billion in the next six years, Hims & Hers recognized a need for the convenience of high quality product bundles that can help consumers feel secure in their intimate experiences. As a result, the company is unveiling two new kits that feature a selection of its highly popular sexual health products on both Hims & Hers websites.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced its intentions to acquire teledermatology specialist, Apostrophe, as part of the Company's ongoing excellence-based category expansion. Financial details of the transaction will not be disclosed at this time.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced the availability of Hims Minoxidil 5% Foam and Hers Minoxidil 5% Foam. These new offerings join the existing Hims Minoxidil 5% solution and Hers Minoxidil 2% solution to provide consumers with even more topical hair regrowth options to fit their individual needs. As a longtime Minoxidil user, global superstar and Hims & Hers investor — Jennifer Lopez also joins the brand in celebrating the new product offerings and the level of personalization it brings to consumers.

Hims & Hers Health, Inc., the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to all consumers, today announced plans to expand their UK footprint and acquire London-based vertical health platform, Honest Health. Honest Health offers consumers hair loss-related products, including access to compounded products, such as a topical Finasteride with Minoxidil solution when appropriate, through an exclusive relationship with the first UK compounding pharmacy and fulfillment center. The proposed transaction provides Hims & Hers with best-in-class operational capability and infrastructure to support the beginnings of the Company’s long-term plans for expansion across the United Kingdom and Western Europe. Financial details of the transaction will not be disclosed at this time.

Hims & Hers, the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced Multi-Platinum Selling Recording Artist, Songwriter and Trailblazer Miley Cyrus has joined the Company as a Creative Advisor. In this role, the icon of authenticity will collaborate with the Company on the Hers line of prescription skincare products, beginning with a series of new advertising campaigns and social content.

Hims & Hers, the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to all consumers, is now offering men access to a convenient treatment for hair loss that combines two clinically-proven ingredients into a single spray. The Topical Finasteride & Minoxidil Spray is a pill-free prescription alternative to traditional oral finasteride treatment that provides effective support for male pattern hair loss. Featuring minoxidil 6% and finasteride 0.1%, the spray is available for appropriate customers with a prescription from a licensed medical professional through Hims & Hers platform, with consultations available at www.forhims.com.

Hims & Hers, the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to all consumers, has partnered with Alex Rodriguez to launch The Blur Stick – a new skincare solution developed specifically for men. Built to complement fan-favorite Hims products such as the Goodnight Wrinkle Cream and Customized Acne Cream, the new Blur Stick features premium ingredients like jojoba oil and aloe extract packaged in a sleek, travel-friendly tube that glides on quickly and provides long-lasting coverage for a diverse range of skin tones and textures. The Hims Blur Stick ($22) is available in eight unique shades exclusively at www.forhims.com.